SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-015030
Filing Date
2019-05-02
Accepted
2019-05-02 07:00:42
Documents
3
Period of Report
2019-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FINANCIAL AND OPERATING RESULTS 1Q2019 atrs-8k_20190502.htm 8-K 36395
2 EX-99.1 PRESS RELEASE atrs-ex991_6.htm EX-99.1 182206
3 GRAPHIC gzdgdhrraofo000001.jpg GRAPHIC 17898
  Complete submission text file 0001564590-19-015030.txt   244804
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 19789661
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10